カテゴリー： QYResearch, 世界

世界の横紋筋肉腫薬市場 2019年

【英語タイトル】Global Rhabdomyosarcoma Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X14406）・商品コード：DATA909X14406
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：110
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、横紋筋肉腫薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ARI-4175、セリビル、クリゾチニブ、エノブリツズマブ、AT-69、アキシチニブ、その他に、用途別には、研究センター、病院、クリニック、その他にセグメント区分し、横紋筋肉腫薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・横紋筋肉腫薬の世界市場概要
・横紋筋肉腫薬の製造コスト構成分析
・横紋筋肉腫薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・横紋筋肉腫薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・横紋筋肉腫薬のセグメント分析（種類別）
（ARI-4175、セリビル、クリゾチニブ、エノブリツズマブ、AT-69、アキシチニブ、その他）
・横紋筋肉腫薬のセグメント分析（用途別）
（研究センター、病院、クリニック、その他）
・横紋筋肉腫薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Bellicum Pharmaceuticals Inc、Boehringer Ingelheim GmbH、Bristol-Myers Squibb Co、Celgene Corp、Eisai Co Ltd、Epizyme Inc、Exelixis Inc、Iproteos SL、Ipsen SA、MacroGenics Inc、NantKwest Inc、Novartis AG、Noxxon Pharma AG、Pfizer Inc、Taiho Pharmaceutical Co Ltd、Taiwan Liposome Company Ltd、Tarveda Therapeutics Inc、）
・横紋筋肉腫薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Rhabdomyosarcoma Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Rhabdomyosarcoma Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rhabdomyosarcoma Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Rhabdomyosarcoma Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Rhabdomyosarcoma Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Bellicum Pharmaceuticals Inc
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Co
Celgene Corp
Eisai Co Ltd
Epizyme Inc
Exelixis Inc
Iproteos SL
Ipsen SA
MacroGenics Inc
NantKwest Inc
Novartis AG
Noxxon Pharma AG
Pfizer Inc
Taiho Pharmaceutical Co Ltd
Taiwan Liposome Company Ltd
Tarveda Therapeutics Inc

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
ARI-4175
Celyvir
Crizotinib
Enoblituzumab
AT-69
Axitinib
Others

Segment by Application
Research Center
Hospital
Clinic
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Rhabdomyosarcoma Drug
1.1 Definition of Rhabdomyosarcoma Drug
1.2 Rhabdomyosarcoma Drug Segment by Type
1.2.1 Global Rhabdomyosarcoma Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 ARI-4175
1.2.3 Celyvir
1.2.4 Crizotinib
1.2.5 Enoblituzumab
1.2.6 AT-69
1.2.7 Axitinib
1.2.8 Others
1.3 Rhabdomyosarcoma Drug Segment by Applications
1.3.1 Global Rhabdomyosarcoma Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Research Center
1.3.3 Hospital
1.3.4 Clinic
1.3.5 Others
1.4 Global Rhabdomyosarcoma Drug Overall Market
1.4.1 Global Rhabdomyosarcoma Drug Revenue (2014-2025)
1.4.2 Global Rhabdomyosarcoma Drug Production (2014-2025)
1.4.3 North America Rhabdomyosarcoma Drug Status and Prospect (2014-2025)
1.4.4 Europe Rhabdomyosarcoma Drug Status and Prospect (2014-2025)
1.4.5 China Rhabdomyosarcoma Drug Status and Prospect (2014-2025)
1.4.6 Japan Rhabdomyosarcoma Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Rhabdomyosarcoma Drug Status and Prospect (2014-2025)
1.4.8 India Rhabdomyosarcoma Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Rhabdomyosarcoma Drug
2.3 Manufacturing Process Analysis of Rhabdomyosarcoma Drug
2.4 Industry Chain Structure of Rhabdomyosarcoma Drug

3 Development and Manufacturing Plants Analysis of Rhabdomyosarcoma Drug
3.1 Capacity and Commercial Production Date
3.2 Global Rhabdomyosarcoma Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Rhabdomyosarcoma Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Rhabdomyosarcoma Drug Production and Capacity Analysis
4.2 Rhabdomyosarcoma Drug Revenue Analysis
4.3 Rhabdomyosarcoma Drug Price Analysis
4.4 Market Concentration Degree

5 Rhabdomyosarcoma Drug Regional Market Analysis
5.1 Rhabdomyosarcoma Drug Production by Regions
5.1.1 Global Rhabdomyosarcoma Drug Production by Regions
5.1.2 Global Rhabdomyosarcoma Drug Revenue by Regions
5.2 Rhabdomyosarcoma Drug Consumption by Regions
5.3 North America Rhabdomyosarcoma Drug Market Analysis
5.3.1 North America Rhabdomyosarcoma Drug Production
5.3.2 North America Rhabdomyosarcoma Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Rhabdomyosarcoma Drug Import and Export
5.4 Europe Rhabdomyosarcoma Drug Market Analysis
5.4.1 Europe Rhabdomyosarcoma Drug Production
5.4.2 Europe Rhabdomyosarcoma Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Rhabdomyosarcoma Drug Import and Export
5.5 China Rhabdomyosarcoma Drug Market Analysis
5.5.1 China Rhabdomyosarcoma Drug Production
5.5.2 China Rhabdomyosarcoma Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Rhabdomyosarcoma Drug Import and Export
5.6 Japan Rhabdomyosarcoma Drug Market Analysis
5.6.1 Japan Rhabdomyosarcoma Drug Production
5.6.2 Japan Rhabdomyosarcoma Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Rhabdomyosarcoma Drug Import and Export
5.7 Southeast Asia Rhabdomyosarcoma Drug Market Analysis
5.7.1 Southeast Asia Rhabdomyosarcoma Drug Production
5.7.2 Southeast Asia Rhabdomyosarcoma Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Rhabdomyosarcoma Drug Import and Export
5.8 India Rhabdomyosarcoma Drug Market Analysis
5.8.1 India Rhabdomyosarcoma Drug Production
5.8.2 India Rhabdomyosarcoma Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Rhabdomyosarcoma Drug Import and Export

6 Rhabdomyosarcoma Drug Segment Market Analysis (by Type)
6.1 Global Rhabdomyosarcoma Drug Production by Type
6.2 Global Rhabdomyosarcoma Drug Revenue by Type
6.3 Rhabdomyosarcoma Drug Price by Type

7 Rhabdomyosarcoma Drug Segment Market Analysis (by Application)
7.1 Global Rhabdomyosarcoma Drug Consumption by Application
7.2 Global Rhabdomyosarcoma Drug Consumption Market Share by Application (2014-2019)

8 Rhabdomyosarcoma Drug Major Manufacturers Analysis
8.1 Bellicum Pharmaceuticals Inc
8.1.1 Bellicum Pharmaceuticals Inc Rhabdomyosarcoma Drug Production Sites and Area Served
8.1.2 Bellicum Pharmaceuticals Inc Product Introduction, Application and Specification
8.1.3 Bellicum Pharmaceuticals Inc Rhabdomyosarcoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Boehringer Ingelheim GmbH
8.2.1 Boehringer Ingelheim GmbH Rhabdomyosarcoma Drug Production Sites and Area Served
8.2.2 Boehringer Ingelheim GmbH Product Introduction, Application and Specification
8.2.3 Boehringer Ingelheim GmbH Rhabdomyosarcoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Bristol-Myers Squibb Co
8.3.1 Bristol-Myers Squibb Co Rhabdomyosarcoma Drug Production Sites and Area Served
8.3.2 Bristol-Myers Squibb Co Product Introduction, Application and Specification
8.3.3 Bristol-Myers Squibb Co Rhabdomyosarcoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Celgene Corp
8.4.1 Celgene Corp Rhabdomyosarcoma Drug Production Sites and Area Served
8.4.2 Celgene Corp Product Introduction, Application and Specification
8.4.3 Celgene Corp Rhabdomyosarcoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Eisai Co Ltd
8.5.1 Eisai Co Ltd Rhabdomyosarcoma Drug Production Sites and Area Served
8.5.2 Eisai Co Ltd Product Introduction, Application and Specification
8.5.3 Eisai Co Ltd Rhabdomyosarcoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Epizyme Inc
8.6.1 Epizyme Inc Rhabdomyosarcoma Drug Production Sites and Area Served
8.6.2 Epizyme Inc Product Introduction, Application and Specification
8.6.3 Epizyme Inc Rhabdomyosarcoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Exelixis Inc
8.7.1 Exelixis Inc Rhabdomyosarcoma Drug Production Sites and Area Served
8.7.2 Exelixis Inc Product Introduction, Application and Specification
8.7.3 Exelixis Inc Rhabdomyosarcoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Iproteos SL
8.8.1 Iproteos SL Rhabdomyosarcoma Drug Production Sites and Area Served
8.8.2 Iproteos SL Product Introduction, Application and Specification
8.8.3 Iproteos SL Rhabdomyosarcoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Ipsen SA
8.9.1 Ipsen SA Rhabdomyosarcoma Drug Production Sites and Area Served
8.9.2 Ipsen SA Product Introduction, Application and Specification
8.9.3 Ipsen SA Rhabdomyosarcoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 MacroGenics Inc
8.10.1 MacroGenics Inc Rhabdomyosarcoma Drug Production Sites and Area Served
8.10.2 MacroGenics Inc Product Introduction, Application and Specification
8.10.3 MacroGenics Inc Rhabdomyosarcoma Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 NantKwest Inc
8.12 Novartis AG
8.13 Noxxon Pharma AG
8.14 Pfizer Inc
8.15 Taiho Pharmaceutical Co Ltd
8.16 Taiwan Liposome Company Ltd
8.17 Tarveda Therapeutics Inc

9 Development Trend of Analysis of Rhabdomyosarcoma Drug Market
9.1 Global Rhabdomyosarcoma Drug Market Trend Analysis
9.1.1 Global Rhabdomyosarcoma Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Rhabdomyosarcoma Drug Regional Market Trend
9.2.1 North America Rhabdomyosarcoma Drug Forecast 2019-2025
9.2.2 Europe Rhabdomyosarcoma Drug Forecast 2019-2025
9.2.3 China Rhabdomyosarcoma Drug Forecast 2019-2025
9.2.4 Japan Rhabdomyosarcoma Drug Forecast 2019-2025
9.2.5 Southeast Asia Rhabdomyosarcoma Drug Forecast 2019-2025
9.2.6 India Rhabdomyosarcoma Drug Forecast 2019-2025
9.3 Rhabdomyosarcoma Drug Market Trend (Product Type)
9.4 Rhabdomyosarcoma Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Rhabdomyosarcoma Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Rhabdomyosarcoma Drug
Table Global Rhabdomyosarcoma Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Rhabdomyosarcoma Drug Production Market Share by Types in 2018
Figure ARI-4175 Product Picture
Figure Celyvir Product Picture
Figure Crizotinib Product Picture
Figure Enoblituzumab Product Picture
Figure AT-69 Product Picture
Figure Axitinib Product Picture
Figure Others Product Picture
Table Global Rhabdomyosarcoma Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Rhabdomyosarcoma Drug Consumption Market Share by Applications in 2018
Figure Research Center
Figure Hospital
Figure Clinic
Figure Others
Figure Global Rhabdomyosarcoma Drug Revenue (Million USD) (2014-2025)
Figure Global Rhabdomyosarcoma Drug Production (K Pcs) (2014-2025)
Figure North America Rhabdomyosarcoma Drug Market Size (Million USD) (2014-2025)
Figure Europe Rhabdomyosarcoma Drug Market Size (Million USD) (2014-2025)
Figure China Rhabdomyosarcoma Drug Market Size (Million USD) (2014-2025)
Figure Japan Rhabdomyosarcoma Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Rhabdomyosarcoma Drug Market Size (Million USD) (2014-2025)
Figure India Rhabdomyosarcoma Drug Market Size (Million USD) (2014-2025)
Table Rhabdomyosarcoma Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Rhabdomyosarcoma Drug in 2018
Figure Manufacturing Process Analysis of Rhabdomyosarcoma Drug
Figure Industry Chain Structure of Rhabdomyosarcoma Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Rhabdomyosarcoma Drug Manufacturing Plants Distribution
Table Rhabdomyosarcoma Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Rhabdomyosarcoma Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Rhabdomyosarcoma Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Rhabdomyosarcoma Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Rhabdomyosarcoma Drug Production Share by Manufacturers in 2018
Table Rhabdomyosarcoma Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Rhabdomyosarcoma Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Rhabdomyosarcoma Drug Revenue Share by Manufacturers in 2018
Table Rhabdomyosarcoma Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Rhabdomyosarcoma Drug Production by Regions 2014-2019 (K Pcs)
Table Global Rhabdomyosarcoma Drug Production Market Share by Regions 2014-2019
Figure Global Rhabdomyosarcoma Drug Production Market Share by Regions in 2018
Table Global Rhabdomyosarcoma Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Rhabdomyosarcoma Drug Revenue Market Share by Regions 2014-2019
Figure Global Rhabdomyosarcoma Drug Revenue Market Share by Regions in 2018
Table Global Rhabdomyosarcoma Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Rhabdomyosarcoma Drug Consumption Market Share by Regions 2014-2019
Figure North America Rhabdomyosarcoma Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Rhabdomyosarcoma Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Rhabdomyosarcoma Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Rhabdomyosarcoma Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Rhabdomyosarcoma Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Rhabdomyosarcoma Drug Production, Consumption Import and Export (K Pcs)
Figure China Rhabdomyosarcoma Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Rhabdomyosarcoma Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Rhabdomyosarcoma Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Rhabdomyosarcoma Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Rhabdomyosarcoma Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Rhabdomyosarcoma Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Rhabdomyosarcoma Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Rhabdomyosarcoma Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Rhabdomyosarcoma Drug Production, Consumption Import and Export (K Pcs)
Figure India Rhabdomyosarcoma Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Rhabdomyosarcoma Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Rhabdomyosarcoma Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Rhabdomyosarcoma Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Rhabdomyosarcoma Drug Market Share by Application (2014-2019)
Table Bellicum Pharmaceuticals Inc Rhabdomyosarcoma Drug Production Sites and Area Served
Table Bellicum Pharmaceuticals Inc Rhabdomyosarcoma Drug Product Introduction, Application and Specification
Table Bellicum Pharmaceuticals Inc Rhabdomyosarcoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bellicum Pharmaceuticals Inc Rhabdomyosarcoma Drug Production Growth Rate (2014-2019)
Table Bellicum Pharmaceuticals Inc Rhabdomyosarcoma Drug Production Market Share (2014-2019)
Figure Bellicum Pharmaceuticals Inc Rhabdomyosarcoma Drug Revenue Market Share (2014-2019)
Table Bellicum Pharmaceuticals Inc Rhabdomyosarcoma Drug Main Business and Markets Served
Table Boehringer Ingelheim GmbH Rhabdomyosarcoma Drug Production Sites and Area Served
Table Boehringer Ingelheim GmbH Rhabdomyosarcoma Drug Product Introduction, Application and Specification
Table Boehringer Ingelheim GmbH Rhabdomyosarcoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Boehringer Ingelheim GmbH Rhabdomyosarcoma Drug Production Growth Rate (2014-2019)
Table Boehringer Ingelheim GmbH Rhabdomyosarcoma Drug Production Market Share (2014-2019)
Figure Boehringer Ingelheim GmbH Rhabdomyosarcoma Drug Revenue Market Share (2014-2019)
Table Boehringer Ingelheim GmbH Rhabdomyosarcoma Drug Main Business and Markets Served
Table Bristol-Myers Squibb Co Rhabdomyosarcoma Drug Production Sites and Area Served
Table Bristol-Myers Squibb Co Rhabdomyosarcoma Drug Product Introduction, Application and Specification
Table Bristol-Myers Squibb Co Rhabdomyosarcoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Co Rhabdomyosarcoma Drug Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Co Rhabdomyosarcoma Drug Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Co Rhabdomyosarcoma Drug Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Co Rhabdomyosarcoma Drug Main Business and Markets Served
Table Celgene Corp Rhabdomyosarcoma Drug Production Sites and Area Served
Table Celgene Corp Rhabdomyosarcoma Drug Product Introduction, Application and Specification
Table Celgene Corp Rhabdomyosarcoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Celgene Corp Rhabdomyosarcoma Drug Production Growth Rate (2014-2019)
Table Celgene Corp Rhabdomyosarcoma Drug Production Market Share (2014-2019)
Figure Celgene Corp Rhabdomyosarcoma Drug Revenue Market Share (2014-2019)
Table Celgene Corp Rhabdomyosarcoma Drug Main Business and Markets Served
Table Eisai Co Ltd Rhabdomyosarcoma Drug Production Sites and Area Served
Table Eisai Co Ltd Rhabdomyosarcoma Drug Product Introduction, Application and Specification
Table Eisai Co Ltd Rhabdomyosarcoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eisai Co Ltd Rhabdomyosarcoma Drug Production Growth Rate (2014-2019)
Table Eisai Co Ltd Rhabdomyosarcoma Drug Production Market Share (2014-2019)
Figure Eisai Co Ltd Rhabdomyosarcoma Drug Revenue Market Share (2014-2019)
Table Eisai Co Ltd Rhabdomyosarcoma Drug Main Business and Markets Served
Table Epizyme Inc Rhabdomyosarcoma Drug Production Sites and Area Served
Table Epizyme Inc Rhabdomyosarcoma Drug Product Introduction, Application and Specification
Table Epizyme Inc Rhabdomyosarcoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Epizyme Inc Rhabdomyosarcoma Drug Production Growth Rate (2014-2019)
Table Epizyme Inc Rhabdomyosarcoma Drug Production Market Share (2014-2019)
Figure Epizyme Inc Rhabdomyosarcoma Drug Revenue Market Share (2014-2019)
Table Epizyme Inc Rhabdomyosarcoma Drug Main Business and Markets Served
Table Exelixis Inc Rhabdomyosarcoma Drug Production Sites and Area Served
Table Exelixis Inc Rhabdomyosarcoma Drug Product Introduction, Application and Specification
Table Exelixis Inc Rhabdomyosarcoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Exelixis Inc Rhabdomyosarcoma Drug Production Growth Rate (2014-2019)
Table Exelixis Inc Rhabdomyosarcoma Drug Production Market Share (2014-2019)
Figure Exelixis Inc Rhabdomyosarcoma Drug Revenue Market Share (2014-2019)
Table Exelixis Inc Rhabdomyosarcoma Drug Main Business and Markets Served
Table Iproteos SL Rhabdomyosarcoma Drug Production Sites and Area Served
Table Iproteos SL Rhabdomyosarcoma Drug Product Introduction, Application and Specification
Table Iproteos SL Rhabdomyosarcoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Iproteos SL Rhabdomyosarcoma Drug Production Growth Rate (2014-2019)
Table Iproteos SL Rhabdomyosarcoma Drug Production Market Share (2014-2019)
Figure Iproteos SL Rhabdomyosarcoma Drug Revenue Market Share (2014-2019)
Table Iproteos SL Rhabdomyosarcoma Drug Main Business and Markets Served
Table Ipsen SA Rhabdomyosarcoma Drug Production Sites and Area Served
Table Ipsen SA Rhabdomyosarcoma Drug Product Introduction, Application and Specification
Table Ipsen SA Rhabdomyosarcoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Ipsen SA Rhabdomyosarcoma Drug Production Growth Rate (2014-2019)
Table Ipsen SA Rhabdomyosarcoma Drug Production Market Share (2014-2019)
Figure Ipsen SA Rhabdomyosarcoma Drug Revenue Market Share (2014-2019)
Table Ipsen SA Rhabdomyosarcoma Drug Main Business and Markets Served
Table MacroGenics Inc Rhabdomyosarcoma Drug Production Sites and Area Served
Table MacroGenics Inc Rhabdomyosarcoma Drug Product Introduction, Application and Specification
Table MacroGenics Inc Rhabdomyosarcoma Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table MacroGenics Inc Rhabdomyosarcoma Drug Production Growth Rate (2014-2019)
Table MacroGenics Inc Rhabdomyosarcoma Drug Production Market Share (2014-2019)
Figure MacroGenics Inc Rhabdomyosarcoma Drug Revenue Market Share (2014-2019)
Table MacroGenics Inc Rhabdomyosarcoma Drug Main Business and Markets Served
Table NantKwest Inc Rhabdomyosarcoma Drug Production Sites and Area Served
Table Novartis AG Rhabdomyosarcoma Drug Production Sites and Area Served
Table Noxxon Pharma AG Rhabdomyosarcoma Drug Production Sites and Area Served
Table Pfizer Inc Rhabdomyosarcoma Drug Production Sites and Area Served
Table Taiho Pharmaceutical Co Ltd Rhabdomyosarcoma Drug Production Sites and Area Served
Table Taiwan Liposome Company Ltd Rhabdomyosarcoma Drug Production Sites and Area Served
Table Tarveda Therapeutics Inc Rhabdomyosarcoma Drug Production Sites and Area Served
Figure Global Rhabdomyosarcoma Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Rhabdomyosarcoma Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Rhabdomyosarcoma Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Rhabdomyosarcoma Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Rhabdomyosarcoma Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Rhabdomyosarcoma Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Rhabdomyosarcoma Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Rhabdomyosarcoma Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Rhabdomyosarcoma Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Rhabdomyosarcoma Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Rhabdomyosarcoma Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Rhabdomyosarcoma Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Rhabdomyosarcoma Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Rhabdomyosarcoma Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Rhabdomyosarcoma Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Rhabdomyosarcoma Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Rhabdomyosarcoma Drug by Application (2019-2025)
Table Rhabdomyosarcoma Drug Distributors List
Table Rhabdomyosarcoma Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Bellicum Pharmaceuticals Inc、Boehringer Ingelheim GmbH、Bristol-Myers Squibb Co、Celgene Corp、Eisai Co Ltd、Epizyme Inc、Exelixis Inc、Iproteos SL、Ipsen SA、MacroGenics Inc、NantKwest Inc、Novartis AG、Noxxon Pharma AG、Pfizer Inc、Taiho Pharmaceutical Co Ltd、Taiwan Liposome Company Ltd、Tarveda Therapeutics Inc、

★調査レポート[世界の横紋筋肉腫薬市場 2019年] (コード：DATA909X14406)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の横紋筋肉腫薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 胞巣状横紋筋肉腫治療の世界市場：規模・現状・予測2019-2025
    DATA909X18151 / QYResearch / 2019年11月25日 / ※当調査レポートでは、胞巣状横紋筋肉腫治療の世界市場について調査・分析し、胞巣状横紋筋肉腫治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（外科手術、化学療法、放射線療法）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の胞巣状横紋筋肉腫治療市場動向 ・主要企業別マーケットシェア ・胞巣状横紋筋肉腫治療の種類別市場規模2014-2019 （外科手術、化学療法、放射線療法） ・胞巣状横紋筋肉腫治療の用途別市場規模2014-2019 （病院、クリニック、その他） ・胞巣状横紋筋肉腫治療の北米市場：主要企業・種類別/用途別市場規模 ・胞巣状横紋筋肉腫治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Alveolar rhabdomyosarcoma (ARMS) is a type of soft tissue sarcoma that originates from the connective tissues of the body such as bone, muscle, cartilage, and ligaments.In 2018, the global Alveolar Rhabdomyosarcoma Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Alveolar Rhabdomyosarcoma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Alveolar Rhabdomyosarcoma Treatment development in North America, Europe and Asia-Pacific. The key players covered in...
  • 世界のタミフル（オセルタミビル）薬市場 2019年
    DATA909X16262 / QYResearch / 2019年11月22日 / ※本調査レポートは、タミフル（オセルタミビル）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、カプセル、経口液に、用途別には、インフルエンザA、インフルエンザBにセグメント区分し、タミフル（オセルタミビル）薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・タミフル（オセルタミビル）薬の世界市場概要 ・タミフル（オセルタミビル）薬の製造コスト構成分析 ・タミフル（オセルタミビル）薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・タミフル（オセルタミビル）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・タミフル（オセルタミビル）薬のセグメント分析（種類別） （カプセル、経口液）...The global Tamiflu (Oseltamivir) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tamiflu (Oseltamivir) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tamiflu (Oseltamivir) Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Tamiflu (Oseltamivir) Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の甲状腺機能低下症薬市場 2019年
    DATA909X09522 / QYResearch / 2019年11月20日 / ※本調査レポートは、甲状腺機能低下症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他に、用途別には、病院、診療所、その他にセグメント区分し、甲状腺機能低下症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・甲状腺機能低下症薬の世界市場概要 ・甲状腺機能低下症薬の製造コスト構成分析 ・甲状腺機能低下症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・甲状腺機能低下症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・甲状腺機能低下症薬のセグメント分析（種類別） （BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他）...The global Hypothyroidism Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hypothyroidism Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hypothyroidism Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Hypothyroidism Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Hypothyroidism Drug manufacturing...
  • 世界のコクシジオイデス症薬剤市場 2019年
    DATA909X05597 / QYResearch / 2019年11月15日 / ※本調査レポートは、コクシジオイデス症薬剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他に、用途別には、クリニック、病院、その他にセグメント区分し、コクシジオイデス症薬剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・コクシジオイデス症薬剤の世界市場概要 ・コクシジオイデス症薬剤の製造コスト構成分析 ・コクシジオイデス症薬剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・コクシジオイデス症薬剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・コクシジオイデス症薬剤のセグメント分析（種類別） （VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他）...The global Coccidioidomycosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Coccidioidomycosis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Coccidioidomycosis Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Coccidioidomycosis Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Coccidioidomycosis Drug manufacturing...
  • 世界のファンコニ貧血薬市場 2019年
    DATA909X07597 / QYResearch / 2019年11月15日 / ※本調査レポートは、ファンコニ貧血薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エルトロンボパグオラミン、EXG-34217、ファンカレン、その他に、用途別には、病院、診療所、その他にセグメント区分し、ファンコニ貧血薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ファンコニ貧血薬の世界市場概要 ・ファンコニ貧血薬の製造コスト構成分析 ・ファンコニ貧血薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ファンコニ貧血薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ファンコニ貧血薬のセグメント分析（種類別） （エルトロンボパグオラミン、EXG-34217、ファンカレン、その他）...The global Fanconi Anemia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Fanconi Anemia Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Fanconi Anemia Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Fanconi Anemia Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の退形成性乏突起膠腫薬市場 2019年
    DATA909X03539 / QYResearch / 2019年11月15日 / ※本調査レポートは、退形成性乏突起膠腫薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、CDX-1401、デパツキシズマブマフォドチン、フルシトシン、その他に、用途別には、病院、クリニック、研究センターにセグメント区分し、退形成性乏突起膠腫薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・退形成性乏突起膠腫薬の世界市場概要 ・退形成性乏突起膠腫薬の製造コスト構成分析 ・退形成性乏突起膠腫薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・退形成性乏突起膠腫薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・退形成性乏突起膠腫薬のセグメント分析（種類別） （CDX-1401、デパツキシズマブマフォドチン、フルシトシン、その他）...The global Anaplastic Oligoastrocytoma Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Anaplastic Oligoastrocytoma Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anaplastic Oligoastrocytoma Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Anaplastic Oligoastrocytoma Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の緑膿菌肺炎治療薬市場 2019年
    DATA909X13859 / QYResearch / 2019年11月20日 / ※本調査レポートは、緑膿菌肺炎治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アエルシン、EV-035、MEDI-3902、パノバクマブ、その他に、用途別には、病院、クリニック、その他にセグメント区分し、緑膿菌肺炎治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・緑膿菌肺炎治療薬の世界市場概要 ・緑膿菌肺炎治療薬の製造コスト構成分析 ・緑膿菌肺炎治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・緑膿菌肺炎治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・緑膿菌肺炎治療薬のセグメント分析（種類別） （アエルシン、EV-035、MEDI-3902、パノバクマブ、その他）...The global Pseudomonas Aeruginosa Pneumonia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Pseudomonas Aeruginosa Pneumonia Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pseudomonas Aeruginosa Pneumonia Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Pseudomonas Aeruginosa Pneumonia Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...

    • ◆H&Iグローバルリサーチのお客様（例）◆